Lee Briton, Dane Bari, Katz Seymour
Department of Medicine, NYU Langone Medical Center, New York, New York.
Department of Radiology, NYU Langone Medical Center, New York, New York.
Gastroenterol Hepatol (N Y). 2022 Apr;18(4):186-195.
The management and understanding of Crohn's disease (CD) continues to evolve quickly. Intestinal strictures were previously thought to be an inevitable result of irreversible fibrosis caused by chronic inflammation. However, increased understanding of the dynamic nature of strictures and of the pathophysiology of this condition has highlighted emerging targets for potential treatment. In the diagnosis of strictures, a distinction must be made between inflammatory and fibrotic types, as the former may respond to medical therapy. Emerging technologies, such as dual-energy computed tomography enterography and iodine density, have allowed more accurate characterization of strictures. Surgical and endoscopic treatment remains the mainstay for fibrotic strictures, but developments in systemic and intralesional biologic therapy have shown efficacy. This article reviews the pathophysiology of this debilitating complication of CD as well as current and emerging diagnostics and treatments.
对克罗恩病(CD)的管理和理解仍在迅速发展。肠道狭窄以前被认为是慢性炎症导致的不可逆纤维化的必然结果。然而,对狭窄动态性质及其病理生理学的深入了解凸显了潜在治疗的新靶点。在狭窄的诊断中,必须区分炎症性和纤维化类型,因为前者可能对药物治疗有反应。双能计算机断层扫描小肠造影和碘密度等新兴技术能够更准确地对狭窄进行特征描述。手术和内镜治疗仍然是纤维化狭窄的主要治疗手段,但全身和病灶内生物治疗的进展已显示出疗效。本文综述了CD这种使人衰弱的并发症的病理生理学以及当前和新兴的诊断方法与治疗手段。